Tendencias21

Novel monoclonal antibody inhibits tumor growth in breast cancer and angiosarcoma

A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma.

Fuente : http://www.eurekalert.org/pub_releases/2013-04/uon…

RedacciónT21

RedacciónT21

Hacer un comentario